推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 2016年6月6日,北京穎泰嘉和生物科技股份有限公司(以下簡(jiǎn)稱“穎泰生物”)宣布收購(gòu)陶氏益農(nóng)旗下全球的特丁噻草隆業(yè)務(wù)。穎泰生物此次收購(gòu)的資產(chǎn)包括特丁噻草隆原藥及其品牌制劑在全球的登記注冊(cè)、商標(biāo)、相關(guān)的生產(chǎn)技術(shù)和登記資料等知識(shí)產(chǎn)權(quán)，以及客戶資料等市場(chǎng)信息。
穎泰生物將授權(quán)陶氏益農(nóng)繼續(xù)銷售特丁噻草隆Spike®, Graslan®, Molopo®, Combine®等品牌制劑產(chǎn)品，產(chǎn)品由穎泰生物獨(dú)家生產(chǎn)供應(yīng)。特丁噻草隆是一種非選擇性取代脲類除草劑，主要用于防除甘蔗田、牧場(chǎng)和非耕地的一年生和多年生的禾本科和闊葉雜草，以及灌木等。此次收購(gòu)有利于穎泰生物擴(kuò)大既有原藥生產(chǎn)規(guī)模，并更加擴(kuò)大和豐富自身產(chǎn)品組合。
此次交易預(yù)計(jì)在2016年上半年完成，協(xié)議內(nèi)容和交易金額事項(xiàng)不會(huì)公告披露。
